| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |